{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T07:24:41Z","timestamp":1786951481026,"version":"build-2736575974"},"reference-count":64,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"unspecified","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002704","name":"Fundaci\u00f3n Cient\u00edfica Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer","doi-asserted-by":"publisher","award":["INVES223049AREC"],"award-info":[{"award-number":["INVES223049AREC"]}],"id":[{"id":"10.13039\/501100002704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002704","name":"Fundaci\u00f3n Cient\u00edfica Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer","doi-asserted-by":"publisher","award":["PRDNA258508ROJO"],"award-info":[{"award-number":["PRDNA258508ROJO"]}],"id":[{"id":"10.13039\/501100002704","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Eurorregi\u00f3n Nueva Aquitania Euskadi Navarra","award":["2020\/101"],"award-info":[{"award-number":["2020\/101"]}]},{"name":"Eurorregi\u00f3n Nueva Aquitania Euskadi Navarra","award":["2023\/2"],"award-info":[{"award-number":["2023\/2"]}]},{"DOI":"10.13039\/501100016120","name":"Departamento de Salud Gobierno de Navarra","doi-asserted-by":"crossref","award":["42\/2021"],"award-info":[{"award-number":["42\/2021"]}],"id":[{"id":"10.13039\/501100016120","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI22\/00471"],"award-info":[{"award-number":["PI22\/00471"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI25\/01079"],"award-info":[{"award-number":["PI25\/01079"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Union Horizon Transcan","award":["2022\u2013784-024"],"award-info":[{"award-number":["2022\u2013784-024"]}]},{"name":"Rolf M Schwiete Foundation","award":["2024\u2013040"],"award-info":[{"award-number":["2024\u2013040"]}]},{"DOI":"10.13039\/100011033","name":"Thermo Fisher Scientific","doi-asserted-by":"publisher","award":["2022 Oncomine Clinical Research Grant"],"award-info":[{"award-number":["2022 Oncomine Clinical Research Grant"]}],"id":[{"id":"10.13039\/100011033","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["egastro"],"accepted":{"date-parts":[[2026,6,24]]},"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Accurate discrimination of malignant versus benign biliary strictures remains clinically challenging. We previously showed that targeted bile cell-free DNA (cfDNA) mutation analysis (Bilemut assay) enables sensitive detection of malignancy, but it does not distinguish cholangiocarcinoma (CCA) from pancreatic ductal adenocarcinoma (PDAC), and its prognostic value remains unclear. In this study, we evaluated ultra-low-pass whole-genome sequencing (ULP-WGS) of bile cfDNA as a potentially cost-effective, technically simple and low-DNA input demanding genomic approach for early tumour detection, tumour-origin discrimination and prognostic stratification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Bile samples from 95 patients with biliary strictures under radiological suspicion of malignancy, classified as malignant (n=26) or indeterminate (n=69) based on the result of cytology or biopsy at the first endoscopic retrograde cholangiopancreatography (ERCP), were analysed by ULP-WGS. Tumour fraction (TF) and copy-number alterations (CNAs) were inferred using ichorCNA. Tumour mutational burden (TMB) was assessed with the Bilemut panel. Overall survival was analysed by Kaplan-Meier analysis and log-rank test. A supervised classifier based on discriminant analysis of principal components was used to distinguish CCA from PDAC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In matched samples, bile LP-WGS showed higher sensitivity than plasma for tumour detection. Among patients with an initial malignant diagnosis, bile ULP-WGS detected circulating tumour DNA (ctDNA) in 73% of cases. In patients initially classified as indeterminate but later confirmed as malignant, tumour DNA was detected in 51%, anticipating final diagnosis by a median of 38 days; notably, in seven patients, ctDNA was detectable more than 100 days before routine diagnosis, highlighting its potential for very early tumour detection. Specificity in strictures with a final benign outcome was 96%. CNA profiling revealed recurrent chromosomal alterations consistent with tissue-based data, and a 50-region CNA classifier discriminated CCA from PDAC with an accuracy of 0.864. Although neither TF nor TMB alone was associated with overall survival, their combination identified a subgroup with poorer prognosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our exploratory study shows that bile ULP-WGS performed at the first ERCP could represent a complementary, scalable and potentially cost-effective genomic strategy for early malignancy detection in biliary strictures, with additional value for tumour-origin classification and, combined with TMB analysis, for identifying patients with poorer prognosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/egastro-2026-100425","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T14:05:18Z","timestamp":1785506718000},"page":"e100425","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Ultra-low-pass whole-genome sequencing of bile cfDNA in patients with biliary strictures"],"prefix":"10.1136","volume":"4","author":[{"given":"Carla","family":"Rojo","sequence":"first","affiliation":[{"name":"Hepatology Laboratory, Solid Tumors Program, CIMA, CCUN, University of Navarra, Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Rullan","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Navarra University Hospital, Pamplona, Spain"},{"name":"IdiSNA, Navarra Institute for Health Research, Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Sogbe","sequence":"additional","affiliation":[{"name":"IdiSNA, Navarra Institute for Health Research, Pamplona, Spain"},{"name":"Liver Unit and HPB Oncology Area, Clinica Universidad de Navarra, Pamplona, Spain"},{"name":"National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd, Carlos III Health Institute), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Maria","family":"Herranz","sequence":"additional","affiliation":[{"name":"Hepatology Laboratory, Solid Tumors Program, CIMA, CCUN, University of Navarra, Pamplona, Spain"},{"name":"National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd, Carlos III Health Institute), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Elizalde","sequence":"additional","affiliation":[{"name":"Hepatology Laboratory, Solid Tumors Program, CIMA, CCUN, University of Navarra, Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Oy\u00f3n","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan J","family":"Vila","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Navarra University Hospital, Pamplona, Spain"},{"name":"IdiSNA, Navarra Institute for Health Research, Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Purroy","sequence":"additional","affiliation":[{"name":"IdiSNA, Navarra Institute for Health Research, Pamplona, Spain"},{"name":"Biobank Unit, Navarrabiomed, Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Azkona","sequence":"additional","affiliation":[{"name":"Hepatology Laboratory, Solid Tumors Program, CIMA, CCUN, University of Navarra, Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco P","family":"Marchese","sequence":"additional","affiliation":[{"name":"Genomics Unit, CIMA Universidad de Navarra, Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Krawczyk","sequence":"additional","affiliation":[{"name":"Department of General, Transplant and Liver Surgery, Medical University of Warsaw, Warsaw, Poland"},{"name":"Department of Gastroenterology, Hepatology and Transplant Medicine, University of Duisburg-Essen, Duisburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maite G","family":"Fern\u00e1ndez-Barrena","sequence":"additional","affiliation":[{"name":"Hepatology Laboratory, Solid Tumors Program, CIMA, CCUN, University of Navarra, Pamplona, Spain"},{"name":"IdiSNA, Navarra Institute for Health Research, Pamplona, Spain"},{"name":"National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd, Carlos III Health Institute), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Sangro","sequence":"additional","affiliation":[{"name":"IdiSNA, Navarra Institute for Health Research, Pamplona, Spain"},{"name":"Liver Unit and HPB Oncology Area, Clinica Universidad de Navarra, Pamplona, Spain"},{"name":"National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd, Carlos III Health Institute), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josepmar\u00eda","family":"Argemi","sequence":"additional","affiliation":[{"name":"Hepatology Laboratory, Solid Tumors Program, CIMA, CCUN, University of Navarra, Pamplona, Spain"},{"name":"IdiSNA, Navarra Institute for Health Research, Pamplona, Spain"},{"name":"Liver Unit and HPB Oncology Area, Clinica Universidad de Navarra, Pamplona, Spain"},{"name":"National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd, Carlos III Health Institute), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Urm\u00e1n","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Navarra University Hospital, Pamplona, Spain"},{"name":"IdiSNA, Navarra Institute for Health Research, Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mat\u00edas A","family":"\u00c1vila","sequence":"additional","affiliation":[{"name":"Hepatology Laboratory, Solid Tumors Program, CIMA, CCUN, University of Navarra, Pamplona, Spain"},{"name":"IdiSNA, Navarra Institute for Health Research, Pamplona, Spain"},{"name":"National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd, Carlos III Health Institute), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Berasain","sequence":"additional","affiliation":[{"name":"Hepatology Laboratory, Solid Tumors Program, CIMA, CCUN, University of Navarra, Pamplona, Spain"},{"name":"National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd, Carlos III Health Institute), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4830-1924","authenticated-orcid":false,"given":"Maria","family":"Arechederra","sequence":"additional","affiliation":[{"name":"Hepatology Laboratory, Solid Tumors Program, CIMA, CCUN, University of Navarra, Pamplona, Spain"},{"name":"IdiSNA, Navarra Institute for Health Research, Pamplona, Spain"},{"name":"National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd, Carlos III Health Institute), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"key":"2026081623400906000_4.3.e100425.1","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2018172424"},{"key":"2026081623400906000_4.3.e100425.2","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.bbadis.2017.09.013","article-title":"The endoscopist and malignant and non-malignant biliary obstruction","volume":"1864","author":"Pereira","year":"2018","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"},{"key":"2026081623400906000_4.3.e100425.3","doi-asserted-by":"publisher","DOI":"10.1177\/1756284820927292"},{"key":"2026081623400906000_4.3.e100425.4","doi-asserted-by":"publisher","DOI":"10.1093\/gastro\/gou072"},{"key":"2026081623400906000_4.3.e100425.5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00795-016-0143-6","article-title":"Adult bile duct strictures: differentiating benign biliary stenosis from cholangiocarcinoma","volume":"49","author":"Nguyen Canh","year":"2016","journal-title":"Med Mol Morphol"},{"key":"2026081623400906000_4.3.e100425.6","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1055\/a-2481-7048","article-title":"Diagnostic work-up of bile duct strictures: European Society of Gastrointestinal Endoscopy (ESGE) Guideline","volume":"57","author":"Facciorusso","year":"2025","journal-title":"Endoscopy"},{"key":"2026081623400906000_4.3.e100425.7","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.bbadis.2017.08.002","article-title":"The search for novel diagnostic and prognostic biomarkers in cholangiocarcinoma","volume":"1864","author":"Macias","year":"2018","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"},{"key":"2026081623400906000_4.3.e100425.8","doi-asserted-by":"crossref","first-page":"699401","DOI":"10.3389\/fonc.2021.699401","article-title":"Biliary Strictures and Cholangiocarcinoma \u2013 Untangling a Diagnostic Conundrum","volume":"11","author":"Ney","year":"2021","journal-title":"Front Oncol"},{"key":"2026081623400906000_4.3.e100425.9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11894-020-00797-9","article-title":"Determining the Indeterminate Biliary Stricture: Cholangioscopy and Beyond","volume":"22","author":"Martinez","year":"2020","journal-title":"Curr Gastroenterol Rep"},{"key":"2026081623400906000_4.3.e100425.10","doi-asserted-by":"crossref","DOI":"10.1136\/egastro-2023-100045","article-title":"Treatment of cholangiocarcinoma in patients with primary sclerosing cholangitis: a comprehensive review","volume":"2","author":"Villard","year":"2024","journal-title":"eGastroenterology"},{"key":"2026081623400906000_4.3.e100425.11","doi-asserted-by":"crossref","first-page":"20200009","DOI":"10.1515\/almed-2020-0009","article-title":"Liquid biopsy for cancer management: a revolutionary but still limited new tool for precision medicine","volume":"1","author":"Arechederra","year":"2020","journal-title":"Advances in Laboratory Medicine \/ Avances En Medicina de Laboratorio"},{"key":"2026081623400906000_4.3.e100425.12","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2017.7"},{"key":"2026081623400906000_4.3.e100425.13","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ajpath.2024.06.013","article-title":"The Search for Risk, Diagnostic, and Prognostic Biomarkers of Cholangiocarcinoma and Their Biological and Clinicopathologic Significance","volume":"195","author":"Macias","year":"2025","journal-title":"Am J Pathol"},{"key":"2026081623400906000_4.3.e100425.14","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-327099"},{"key":"2026081623400906000_4.3.e100425.15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.37349\/edd.2024.00037","article-title":"Bile as a liquid biopsy matrix: potential applications and limitations","volume":"3","author":"Arechederra","year":"2024","journal-title":"Explor Dig Dis"},{"key":"2026081623400906000_4.3.e100425.16","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-325178"},{"key":"2026081623400906000_4.3.e100425.17","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100275","article-title":"Cell-free DNA from bile outperformed plasma as a potential alternative to tissue biopsy in biliary tract cancer","volume":"6","author":"Gou","year":"2021","journal-title":"ESMO Open"},{"key":"2026081623400906000_4.3.e100425.18","doi-asserted-by":"crossref","first-page":"362","DOI":"10.37349\/etat.2022.00087","article-title":"Liquid biopsy in biliary tract cancer from blood and bile samples: current knowledge and future perspectives","volume":"3","author":"Arrichiello","year":"2022","journal-title":"Exploration of Targeted Anti-Tumor Therapy"},{"key":"2026081623400906000_4.3.e100425.19","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13010039","article-title":"Bile-Based Cell-Free DNA Analysis Is a Reliable Diagnostic Tool in Pancreatobiliary Cancer","volume":"13","author":"Driescher","year":"2020","journal-title":"Cancers (Basel)"},{"key":"2026081623400906000_4.3.e100425.20","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.3390\/cancers13184581","article-title":"Liquid Biopsy from Bile-Circulating Tumor DNA in Patients with Biliary Tract Cancer","volume":"13","author":"Han","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2026081623400906000_4.3.e100425.21","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.gie.2024.12.024","article-title":"Next-generation sequencing improves the detection of malignant biliary strictures and changes management","volume":"102","author":"Bardhi","year":"2025","journal-title":"Gastrointest Endosc"},{"key":"2026081623400906000_4.3.e100425.22","doi-asserted-by":"crossref","DOI":"10.1111\/liv.70049","article-title":"Mutational Analysis of Bile Cell-Free DNA in Primary Sclerosing Cholangitis: A Pilot Study","volume":"45","author":"Arechederra","year":"2025","journal-title":"Liver Int"},{"key":"2026081623400906000_4.3.e100425.23","doi-asserted-by":"publisher","DOI":"10.1038\/nature08822"},{"key":"2026081623400906000_4.3.e100425.24","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2760"},{"key":"2026081623400906000_4.3.e100425.25","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-1593"},{"key":"2026081623400906000_4.3.e100425.26","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-00965-y","article-title":"Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors","volume":"8","author":"Adalsteinsson","year":"2017","journal-title":"Nat Commun"},{"key":"2026081623400906000_4.3.e100425.27","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.trsl.2023.07.005","article-title":"Noninvasive early differential diagnosis and progression monitoring of ovarian cancer using the copy number alterations of plasma cell-free DNA","volume":"262","author":"Chen","year":"2023","journal-title":"Translational Research"},{"key":"2026081623400906000_4.3.e100425.28","doi-asserted-by":"crossref","first-page":"100908","DOI":"10.1016\/j.tranon.2020.100908","article-title":"Non-invasive detection of biliary tract cancer by low-coverage whole genome sequencing from plasma cell-free DNA: A prospective cohort study","volume":"14","author":"Wang","year":"2021","journal-title":"Transl Oncol"},{"key":"2026081623400906000_4.3.e100425.29","doi-asserted-by":"crossref","first-page":"110916","DOI":"10.1016\/j.ygeno.2024.110916","article-title":"Identification of whole-genome mutations and structural variations of bile cell-free DNA in cholangiocarcinoma","volume":"116","author":"Yin","year":"2024","journal-title":"Genomics"},{"key":"2026081623400906000_4.3.e100425.30","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/1878-0261.12757","article-title":"Genome-wide profiling of circulating tumor DNA depicts landscape of copy number alterations in pancreatic cancer with liver metastasis","volume":"14","author":"Wei","year":"2020","journal-title":"Mol Oncol"},{"key":"2026081623400906000_4.3.e100425.31","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ads5002","article-title":"Genome-wide analyses of cell-free DNA for therapeutic monitoring of patients with pancreatic cancer","volume":"11","author":"Hruban","year":"2025","journal-title":"Sci Adv"},{"key":"2026081623400906000_4.3.e100425.32","doi-asserted-by":"crossref","DOI":"10.1093\/carcin\/bgae073","article-title":"Prognostic value of circulating tumor DNA in different cancer types detected by ultra-low-pass whole-genome sequencing: a systematic review and patient-level survival data meta-analysis","volume":"46","author":"Sogbe","year":"2025","journal-title":"Carcinogenesis"},{"key":"2026081623400906000_4.3.e100425.33","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.790445","article-title":"Ultra Low-Coverage Whole-Genome Sequencing as an Alternative to Genotyping Arrays in Genome-Wide Association Studies","volume":"12","author":"Chat","year":"2021","journal-title":"Front Genet"},{"key":"2026081623400906000_4.3.e100425.34","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-36801-9","article-title":"Circulating tumor DNA reveals complex biological features with clinical relevance in metastatic breast cancer","volume":"14","author":"Prat","year":"2023","journal-title":"Nat Commun"},{"key":"2026081623400906000_4.3.e100425.35","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.76.0033"},{"key":"2026081623400906000_4.3.e100425.36","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/1878-0261.13409","article-title":"Dynamic changes in circulating tumor DNA assessed by shallow whole-genome sequencing associate with clinical efficacy of checkpoint inhibitors in NSCLC","volume":"17","author":"Carbonell","year":"2023","journal-title":"Mol Oncol"},{"key":"2026081623400906000_4.3.e100425.37","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41416-018-0212-9","article-title":"Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children\u2019s Oncology Group","volume":"119","author":"Shulman","year":"2018","journal-title":"Br J Cancer"},{"key":"2026081623400906000_4.3.e100425.38","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.3390\/cancers12061644","article-title":"Pilot Multi-Omic Analysis of Human Bile from Benign and Malignant Biliary Strictures: A Machine-Learning Approach","volume":"12","author":"Urman","year":"2020","journal-title":"Cancers (Basel)"},{"key":"2026081623400906000_4.3.e100425.39","first-page":"1017","article-title":"Molecular classification of brain tumor biopsies using solid-state magic angle spinning proton magnetic resonance spectroscopy and robust classifiers","volume":"33","author":"Andronesi","year":"2008","journal-title":"Int J Oncol"},{"key":"2026081623400906000_4.3.e100425.40","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v085.i11"},{"key":"2026081623400906000_4.3.e100425.41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174944","article-title":"Can machine-learning improve cardiovascular risk prediction using routine clinical data?","volume":"12","author":"Weng","year":"2017","journal-title":"PLoS ONE"},{"key":"2026081623400906000_4.3.e100425.42","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2156-11-94","article-title":"Discriminant analysis of principal components: a new method for the analysis of genetically structured populations","volume":"11","author":"Jombart","year":"2010","journal-title":"BMC Genet"},{"key":"2026081623400906000_4.3.e100425.43","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-317817"},{"key":"2026081623400906000_4.3.e100425.44","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jhep.2025.05.003","article-title":"Durvalumab plus chemotherapy in advanced biliary tract cancer: 3-year overall survival update from the phase III TOPAZ-1 study","volume":"83","author":"Oh","year":"2025","journal-title":"J Hepatol"},{"key":"2026081623400906000_4.3.e100425.45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003734","article-title":"Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study","volume":"18","author":"Szymanski","year":"2021","journal-title":"PLoS Med"},{"key":"2026081623400906000_4.3.e100425.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2024.01.014"},{"key":"2026081623400906000_4.3.e100425.47","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3350\/cmh.2023.0426","article-title":"Prognostic Value of Ultra-Low-Pass Whole-Genome Sequencing of Circulating Tumor DNA in hepatocellular carcinoma under systemic treatment","volume":"30","author":"Sogbe","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"2026081623400906000_4.3.e100425.48","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-17-0368"},{"key":"2026081623400906000_4.3.e100425.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.07.007"},{"key":"2026081623400906000_4.3.e100425.50","doi-asserted-by":"publisher","DOI":"10.1038\/nature16965"},{"key":"2026081623400906000_4.3.e100425.51","doi-asserted-by":"crossref","DOI":"10.1200\/PO.23.00092","article-title":"Tumor Mutational Burden in Real-World Patients With Pancreatic Cancer: Genomic Alterations and Predictive Value for Immune Checkpoint Inhibitor Effectiveness","volume":"7","author":"Quintanilha","year":"2023","journal-title":"JCO Precis Oncol"},{"key":"2026081623400906000_4.3.e100425.52","doi-asserted-by":"crossref","first-page":"15330338211062324","DOI":"10.1177\/15330338211062324","article-title":"Tumor Mutational Burden as a Biomarker for Advanced Biliary Tract Cancer","volume":"20","author":"Kim","year":"2021","journal-title":"Technol Cancer Res Treat"},{"key":"2026081623400906000_4.3.e100425.53","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210832"},{"key":"2026081623400906000_4.3.e100425.54","doi-asserted-by":"crossref","DOI":"10.1136\/egastro-2024-100074","article-title":"Bile acids regulation of cellular stress responses in liver physiology and diseases","volume":"2","author":"Li","year":"2024","journal-title":"egastro"},{"key":"2026081623400906000_4.3.e100425.55","doi-asserted-by":"crossref","first-page":"12090","DOI":"10.1038\/s41598-025-96170-9","article-title":"Optimization of bile preparation for liquid biopsy in cholangiocarcinoma focusing on circulating tumor DNA and protein stability","volume":"15","author":"Han","year":"2025","journal-title":"Sci Rep"},{"key":"2026081623400906000_4.3.e100425.56","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.trecan.2021.06.001","article-title":"Technical and biological constraints on ctDNA-based genotyping","volume":"7","author":"Herberts","year":"2021","journal-title":"Trends Cancer"},{"key":"2026081623400906000_4.3.e100425.57","first-page":"00176","article-title":"Low Abundance of Circulating Tumor DNA in Localized Prostate Cancer","volume":"3","author":"Hennigan","year":"2019","journal-title":"JCO Precis Oncol"},{"key":"2026081623400906000_4.3.e100425.58","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat4921","article-title":"Enhanced detection of circulating tumor DNA by fragment size analysis","volume":"10","author":"Mouliere","year":"2018","journal-title":"Sci Transl Med"},{"key":"2026081623400906000_4.3.e100425.59","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlb.2023.100003","article-title":"Validity and utility of blood tumor mutational burden (bTMB) is dependent on circulating tumor DNA (ctDNA) shed: SCRUM-Japan MONSTAR-SCREEN","volume":"1","author":"Mishima","year":"2023","journal-title":"J Liq Biopsy"},{"key":"2026081623400906000_4.3.e100425.60","doi-asserted-by":"crossref","first-page":"790","DOI":"10.12998\/wjcc.v10.i3.790","article-title":"High tumor mutation burden indicates a poor prognosis in patients with intrahepatic cholangiocarcinoma","volume":"10","author":"Song","year":"2022","journal-title":"World J Clin Cases"},{"key":"2026081623400906000_4.3.e100425.61","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-021-07788-7","article-title":"Comprehensive analysis of genomic mutation signature and tumor mutation burden for prognosis of intrahepatic cholangiocarcinoma","volume":"21","author":"Zhang","year":"2021","journal-title":"BMC Cancer"},{"key":"2026081623400906000_4.3.e100425.62","doi-asserted-by":"crossref","first-page":"116035","DOI":"10.1016\/j.ejca.2025.116035","article-title":"Genomic pathway alterations and their prognostic impact in biliary tract cancer: Insights from a multinational cohort treated with cisplatin, gemcitabine, and durvalumab","volume":"230","author":"Pirrone","year":"2025","journal-title":"Eur J Cancer"},{"key":"2026081623400906000_4.3.e100425.63","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1038\/s41598-023-31579-8","article-title":"Characterization of pancreatic cancer with ultra-low tumor mutational burden","volume":"13","author":"Imamura","year":"2023","journal-title":"Sci Rep"},{"key":"2026081623400906000_4.3.e100425.64","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-0558"}],"container-title":["eGastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/egastro-2026-100425","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T06:40:23Z","timestamp":1786948823000},"score":1,"resource":{"primary":{"URL":"http:\/\/egastroenterology.bmj.com\/lookup\/doi\/10.1136\/egastro-2026-100425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":64,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,7,31]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1136\/egastro-2026-100425"],"URL":"https:\/\/doi.org\/10.1136\/egastro-2026-100425","relation":{},"ISSN":["2766-0125","2976-7296"],"issn-type":[{"value":"2766-0125","type":"print"},{"value":"2976-7296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]}}}